Arbutus Biopharma Corp - Common Shares, without par value (ABUS)

CUSIP: 03879J100

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Shares, without par value
Shares outstanding
193,679,354
Total 13F shares
104,075,822
Share change
+1,209,069
Total reported value
$340,339,884
Put/Call ratio
103%
Price per share
$3.27
Number of holders
153
Value change
+$3,767,856
Number of buys
69
Number of sells
54

Quarterly Holders Quick Answers

What is CUSIP 03879J100?
CUSIP 03879J100 identifies ABUS - Arbutus Biopharma Corp - Common Shares, without par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q4 2024

As of 31 Dec 2024, Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by 153 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 104,075,822 shares. The largest 10 holders included MORGAN STANLEY, Whitefort Capital Management, LP, BlackRock, Inc., VANGUARD GROUP INC, Two Seas Capital LP, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, BlackBarn Capital Partners LP, Rubric Capital Management LP, and ADAGE CAPITAL PARTNERS GP, L.L.C.. This page lists 153 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.